Nuvara Journal
Written and reviewed by the Nuvara Medical Team — practical, evidence-informed reading on the protocols we prescribe.
GLP 1 receptor agonists have changed the weight management landscape. Semaglutide and tirzepatide — originally developed for type 2 diabetes — have shown signif…
Hormonal decline affects both men and women, typically starting in the 30s and accelerating through the 40s and beyond. Symptoms range from fatigue and weight g…
Semaglutide has become one of the most widely discussed weight loss medications in the United States. Originally developed to treat type 2 diabetes, it gained s…
The telehealth peptide therapy space has grown fast. Dozens of platforms now offer GLP 1 medications, TRT, and peptide protocols online. Choosing the right prov…
When considering peptide therapy or hormone optimization, hearing from other patients helps. Here's what Nuvara Health patients report about their experience —…
GLP 1 receptor agonists have changed the way physicians approach metabolic health. Instead of relying on willpower alone, these medications work with your body'…
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell you have. It powers the reactions that convert food into usable energy and supports…
